Eqis Capital Management, Inc. Liva Nova PLC Transaction History

Eqis Capital Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$57.25 - $86.63 $371,896 - $562,748	-6,496 Reduced 63.82%	3,682 $230,000
Q1 2022 May 16, 2022	SELL	$71.02 - $86.99 $436,346 - $534,466	-6,144 Reduced 37.64%	10,178 $833,000
Q4 2021 Feb 14, 2022	SELL	$76.72 - $92.68 $49,100 - $59,315	-640 Reduced 3.77%	16,322 $1.43 Million
Q3 2021 Nov 12, 2021	SELL	$76.02 - $88.62 $1.16 Million - $1.35 Million	-15,281 Reduced 47.39%	16,962 $1.34 Million
Q2 2021 Aug 12, 2021	BUY	$73.44 - $87.01 $2.37 Million - $2.81 Million	32,243 New	32,243 $2.71 Million
Q2 2018 Jul 27, 2018	SELL	$81.75 - $105.37 $358,555 - $462,152	-4,386 Closed	0 $0
Q1 2018 Apr 06, 2018	BUY	$79.95 - $89.74 $7,595 - $8,525	95 Added 2.21%	4,386 $388,000
Q4 2017 Jan 25, 2018	BUY	$71.8 - $88.21 $308,093 - $378,509	4,291	4,291 $343,000

274

55.2M

140K

44.5K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.23B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.